Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Siena Biotech and Roche collaborate in neurodegenerative diseases

May 25, 2007

Lacosamide filed in Europe as adjunctive therapy of epilepsy

May 25, 2007

VASTox to advance programs targeting symptoms of Parkinson's disease

May 25, 2007

Recent Merck & Co. and Merck Sharp & Dohme patent discloses new antipsychotic agents

May 25, 2007

Milnacipran shows statistically significant therapeutic effects in fibromyalgia

May 24, 2007

SPA reached for second phase III trial of Fampridine-SR

May 24, 2007

Synosia inlicenses new CNS compound to boost pipeline

May 24, 2007

Cymbalta shown to improve functioning in GAD patients

May 24, 2007

AD-923 successfully completes pharmacokinetic study

May 23, 2007

Phase III program planned for bapineuzumab in Alzheimer's

May 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...